Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Non-canonical HIV drug resistance mutations: need to close existing gaps.
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1.
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.
NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial.
A protein synthesis routes.
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Prevalence and severity of anxiety, stress, and depression in long COVID among adults in Barcelona.
Rethinking Optimal Immunogens to Face SARS-CoV-2 Evolution Through Vaccination.